Continuous Glucose Monitoring (CGM): Technologies and Global Markets

Continuous Glucose Monitoring (CGM): Technologies and Global Markets

Report Scope:

The scope of this study encompasses the current and forecast markets for glucose monitoring, connected pumps and pens, SMBG meters, and test strips. The covered segments are CGM transmitters, receivers and sensors, smart pumps and pens, and self-monitoring blood glucose (SMBG) equipment and test strips. The test strip market numbers refer to all types of test strips with SMBG, and not just test strips as used by CGM users. CGM users also use test strips, but theoretically only for calibrating their CGM devices. The report also includes discussions of the market opportunities, patent scenario, market projections and market shares, competitive landscape, and the key company profiles. The report would also cover the COVID-19 impact on the CGM market.

Report Includes:

27 data tables and 28 additional tables

A detailed overview and an up-to-date analysis of the global markets for continuous glucose monitoring (CGM) devices and technologies

Analyses of the global market trends, with historic market revenue (sales figures) for 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

Highlights of market opportunities for this innovation-driven continuous glucose monitoring devices market, and the major regions and countries involved in market developments

Estimation of the actual market size and revenue forecast for CGM devices in USD million values, and corresponding market share analysis by technology type, end-user settings, type of diabetes, user age group, and region

Country specific data and market value analysis for the United States, Canada, Germany, U.K., France, Italy, Japan, China, South Korea, etc.

Reassessment of the critical issues surrounding CGM transmitters/receivers, self-monitoring blood glucose (SMBG) equipment and test strips, and durable insulin pumps; their recent technological advancements, geographic trends, market dynamics, and adoption trends

Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues

Review of the key patent grants and patent applications within select CGM technologies

Company profiles of major players within the industry, including Abbott Laboratories, F. Hoffmann-La Roche, Medtronic PLC, Novo Nordisk, and Sanofi S.A.

Companies Mentioned

ABBOTT LABORATORIES
ASCENSIA DIABETES CARE HOLDINGS AG
Beta Bionics, Inc.
BIGFOOT BIOMEDICAL
DEXCOM INC.
EMPERRA GMBH E-HEALTH TECHNOLOGIES
F. HOFFMANN-LA ROCHE LTD.
Glucotrack, Inc.
INSULET CORP.
INTUITY MEDICAL INC.
LifeScan IP Holdings, LLC
MEDTRONIC PLC
NEMAURA MEDICAL INC.
NOVIOSENSE BV
NOVO NORDISK A/S
PKVITALITY
Qlibrium
SANOFI S.A.
SENSEONICS HOLDINGS INC.
SINOCARE INC.
TANDEM DIABETES CARE
YPSOMED AG